RKLB NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Rocket Lab USA Inc. · Industrials · Aerospace & Defense

Open interactive chart View report data Download investor PDF
Latest close 63.91 USD
-5.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -25.6% below the Trend Line and sits at 23.2% of its 52-week range. The latest completed week returned -5.5%, after a -24.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 40/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 7d.

Setup score 29 out of 100
Latest Close 63.91 USD 24 Jul 2026
1W Return -5.5% latest completed week
4W Return -24.4% short-term follow-through
12W Return -18.9% quarterly tape
Trend Breadth 96.2% 50 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 55.12% based on similar historical setup states.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -5.5% Latest completed week; four-week move -24.4%. Indicator stack 53/18 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.12% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 40/100 conviction; expected move 8.2%. News sentiment 55/100 57 relevant articles in the latest sentiment read. Event risk 7d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -25.6% below the Trend Line and sits at 23.2% of its 52-week range. The latest completed week returned -5.5%, after a -24.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7012-week average 0.65

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -24.4% over four weeks, -18.9% over 12 weeks, and 34.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-5.5%
4W-24.4%
12W-18.9%
26W-28.1%
52W34.7%
Active trend streak0 weeks
Active weeks in one year50
Trend breadth96.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.74Latest activity-pressure read.
Pressure change-235.2%Four-week change in activity pressure.
Leadership-17.18Latest relative-leadership reading.
RS change-301.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength11/100Blend of value, momentum, and quality. Underlying universe rank 90; rank 1 is best.
Value12/100Relative valuation strength. Underlying universe rank 89; rank 1 is best.
Quality6/100Profitability and accounting quality. Underlying universe rank 95; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth85/100Revenue and earnings growth. Underlying universe rank 16; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
58.8x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
36.6%
Gross profit retained from each unit of revenue.
Operating margin
-29.8%
Operating profit retained from revenue.
Free-cash-flow margin
-1.0%
Free cash flow generated from revenue.
Return on invested capital
-12.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
45.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-3.8%
Net share repurchases relative to market value.
Shareholder yield
-3.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
7.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

RKLB shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.41, expected move of 8.2%, and Sharemaestro trend signal inactive.

Conviction40/100
Expected move8.2%
Put/call volume0.41
Pressure46
Speculation42
Volatility89
Trend agreement11
Open options detail
Insider activity0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 57 relevant articles.

16 positive · 35 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move8.2%Nearest-chain priced movement where available.
52-week drawdown-57.7%Distance below the 52-week high.
13-week volatility16.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+33.8%Week of 8 May.
Worst week-23.3%Week of 5 Jun.
Latest week-5.5%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains2
Flat weeks0
Modest losses4
Sharp losses11
Recent vol16.8%13-week weekly-return volatility.
Base vol12.5%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew11.7% / -8.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape35/100

Trend, activity pressure, participation, and risk combine to a 35/100 tape read.

 Indicator analysis70/100

Latest 12-week confirmation: trend 10/12, activity pressure 10/12, relative leadership 9/12.

Activity pressure 0.70; 2 reversal markers Next-Week ExpectancyPositive 55.12%

Next-week expectancy is positive with a 55.12% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors25/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 81 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options45/100

RKLB shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.41, expected move of 8.2%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 8.2% Sentiment55/100

Weighted news tone is neutral across 57 relevant articles.

Rocket Lab’s Bull Case Strengthens On Neutron Progress And Iridium Deal, Says Citizens – Firm Sees 98% Upside Potential For RKLB Insiders0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

 Earnings7d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.

 Research flow1 items

1 recent research articles and 0 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202663.91 USD-5.5%85.94 USD32.65 USD-0.74-17.1892.1MOff
17 Jul 202667.62 USD-16.6%86.17 USD32.29 USD-0.43-13.63103.6MOff
10 Jul 202681.04 USD-19.3%86.27 USD31.90 USD0.01-0.7198.3MOn
3 Jul 2026100.5 USD18.8%85.61 USD31.42 USD0.3426.20119.6MOn
26 Jun 202684.54 USD-21.2%83.90 USD30.81 USD0.548.55138.2MOn
19 Jun 2026107.2 USD4.7%82.49 USD30.31 USD0.9032.77155.9MOn
12 Jun 2026102.4 USD-7.0%80.26 USD29.66 USD1.1532.19139.7MOn
5 Jun 2026110.1 USD-23.3%78.36 USD29.04 USD1.4347.88124.7MOn
29 May 2026143.5 USD5.7%76.41 USD28.37 USD1.6087.53117.5MOn
22 May 2026135.8 USD8.8%73.73 USD27.48 USD1.1187.54148.5MOn
15 May 2026124.8 USD18.3%71.36 USD26.64 USD0.6179.20163.4MOn
8 May 2026105.5 USD33.8%69.41 USD25.87 USD0.1954.84156.0MOn
1 May 202678.81 USD-1.1%68.03 USD25.22 USD-0.3724.7285.5MOn
24 Apr 202679.68 USD-6.0%67.28 USD24.74 USD-0.4629.90122.5MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.